Netherlands-based Royal DSM has acquired a 91.75% stake in China's Shandong ICD High Performance Fiber.
ICD is a manufacturer of ultra high molecular weight polyethylene fibre.
The acquisition brings complementary manufacturing and technology assets to DSM and strengthens the company's presence in this key market.
DSM Managing Board member Nico Gerarduand said the acquisition reflects their continued commitment to China and the strategy of investing in high growth economies.
Financial terms of the deal have not been disclosed.
